Risk of bias in randomized trials of pharmacological interventions in children and adults

Yashwant K Sinha1, Jonathan C Craig2, Premala Sureshkumar3

  • 1Center for Kidney Research, The Children's Hospital at Westmead, Westmead, Australia.

Insights

Pediatric randomized controlled trials show a similar risk of bias compared to adult trials when matched for drug class and therapeutic area. This indicates no inherent difference in the capacity to conduct high-quality research between pediatric and adult studies.

Area of Science:

  • Clinical Trials
  • Pediatric Research
  • Pharmacology

Background:

  • Assessing the quality of evidence from clinical trials is crucial for informed medical decision-making.
  • Concerns exist regarding potential biases in randomized controlled trials (RCTs) involving pediatric populations compared to adults.
  • Understanding these differences is vital for advancing pediatric pharmacologic interventions.

Purpose of the Study:

  • To compare the risk of bias in pediatric pharmacologic RCTs with similar adult trials.
  • To investigate whether disparities in trial quality exist between pediatric and adult research.

Main Methods:

  • A systematic review and matched-pair comparison of pediatric and adult RCTs published in MEDLINE (January 2008-October 2009).
  • Trials were matched by drug class and therapeutic area.
  • The Cochrane risk of bias tool was employed for assessment.

Main Results:

  • Pediatric and adult trials exhibited similar characteristics, with adult studies more frequently conducted in Europe and published in specialty journals.
  • A significant proportion of trials, both pediatric and adult, had an unclear risk of bias for allocation concealment.
  • While initial analysis suggested a lower risk of bias in pediatric trials for random sequence generation and blinding, a sensitivity analysis indicated publication year as a confounder.

Conclusions:

  • When matched for key characteristics, pediatric and adult RCTs demonstrate comparable risks of bias.
  • Differences in reported bias are not attributable to variations in researchers' capacity to conduct high-quality trials.
  • The findings support the potential for high-quality evidence generation in pediatric pharmacology research.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.3K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.6K
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K